• Something wrong with this record ?

Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension

P. Mulatero, S. Monticone, J. Deinum, L. Amar, A. Prejbisz, MC. Zennaro, F. Beuschlein, GP. Rossi, T. Nishikawa, A. Morganti, TM. Seccia, YH. Lin, F. Fallo, J. Widimsky

. 2020 ; 38 (10) : 1919-1928. [pub] -

Language English Country Great Britain

Document type Journal Article

: Autonomous aldosterone overproduction represents the underlying condition of 5-10% of patients with arterial hypertension and carries a significant burden of mortality and morbidity. The diagnostic algorithm for primary aldosteronism is sequentially based on hormonal tests (screening and confirmation tests), followed by lateralization studies (adrenal CT scanning and adrenal venous sampling) to distinguish between unilateral and bilateral disease. Despite the recommendations of the Endocrine Society guideline, primary aldosteronism is largely underdiagnosed and undertreated with high between-centre heterogeneity. Experts from the European Society of Hypertension have critically reviewed the available literature and prepared a consensus document constituting two articles to summarize current knowledge on the epidemiology, diagnosis, treatment, and complications of primary aldosteronism.

3rd Department of Medicine Center for Hypertension General University Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Assistance Publique Hôpitaux de Paris Hôpital Européen Georges Pompidou Service de Génétique Paris France

Centro Fisiologia Clinica e Ipertensione Ospedale Policlinico Università di Milano Milan Italy

Department of Hypertension National Institute of Cardiology Warsaw Poland

Department of Internal Medicine Radboud University Medical Center Nijmegen Netherlands

Department of Medicine 3 University Hospital Carl Gustav Carus at the TU Dresden Dresden Germany

Department of Medicine DIMED University of Padova Padova Italy

Division of cardiology Department of Internal Medicine National Taiwan University Hospital and National Taiwan University College of Medicine Taipei Taiwan

Division of Internal Medicine and Hypertension Unit Department of Medical Sciences University of Torino Torino Italy

Endocrinology and Diabetes Center Yokohama Rosai Hospital Yokohama Japan

Hypertension Unit and Specialized Center for Blood Pressure Disorders Department of Medicine DIMED University of Padova Padova Italy

Hypertension Unit Assistance Publique Hôpitaux de Paris Hôpital européen Georges Pompidou Université de Paris PARCC Inserm Paris France

Klinik für Endokrinologie Diabetologie und Klinische Ernährung Universitätsspital Zürich Zürich Switzerland

Medizinische Klinik und Poliklinik 4 Klinikum der Universität München Munich Germany

Université de Paris PARCC INSERM Paris France

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020063
003      
CZ-PrNML
005      
20210830101654.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1097/HJH.0000000000002510 $2 doi
035    __
$a (PubMed)32890264
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Mulatero, Paolo $u Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino, Italy
245    10
$a Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension / $c P. Mulatero, S. Monticone, J. Deinum, L. Amar, A. Prejbisz, MC. Zennaro, F. Beuschlein, GP. Rossi, T. Nishikawa, A. Morganti, TM. Seccia, YH. Lin, F. Fallo, J. Widimsky
520    9_
$a : Autonomous aldosterone overproduction represents the underlying condition of 5-10% of patients with arterial hypertension and carries a significant burden of mortality and morbidity. The diagnostic algorithm for primary aldosteronism is sequentially based on hormonal tests (screening and confirmation tests), followed by lateralization studies (adrenal CT scanning and adrenal venous sampling) to distinguish between unilateral and bilateral disease. Despite the recommendations of the Endocrine Society guideline, primary aldosteronism is largely underdiagnosed and undertreated with high between-centre heterogeneity. Experts from the European Society of Hypertension have critically reviewed the available literature and prepared a consensus document constituting two articles to summarize current knowledge on the epidemiology, diagnosis, treatment, and complications of primary aldosteronism.
650    _2
$a aldosteron $x krev $7 D000450
650    _2
$a konsensus $7 D032921
650    _2
$a lidé $7 D006801
650    12
$a hyperaldosteronismus $x diagnóza $x epidemiologie $x genetika $7 D006929
650    _2
$a hypertenze $7 D006973
650    _2
$a prevalence $7 D015995
655    _2
$a časopisecké články $7 D016428
700    1_
$a Monticone, Silvia $u Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino, Italy
700    1_
$a Deinum, Jaap $u Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands $u Department of Medicine III, University Hospital Carl Gustav Carus at the TU Dresden, Dresden, Germany
700    1_
$a Amar, Laurence $u Hypertension Unit, Assistance Publique-Hôpitaux de Paris, Hôpital européen Georges-Pompidou, Université de Paris, PARCC, Inserm, Paris, France
700    1_
$a Prejbisz, Aleksander $u Department of Hypertension, National Institute of Cardiology, Warsaw, Poland
700    1_
$a Zennaro, Maria-Christina $u Université de Paris, PARCC, INSERM, Paris, France $u Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Génétique, Paris, France
700    1_
$a Beuschlein, Felix $u Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland $u Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
700    1_
$a Rossi, Gian Paolo $u Hypertension Unit and Specialized Center for Blood Pressure Disorders - Department of Medicine-DIMED, University of Padova, Padova, Italy
700    1_
$a Nishikawa, Tetsuo $u Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan
700    1_
$a Morganti, Alberto $u Centro Fisiologia Clinica e Ipertensione, Ospedale Policlinico, Università di Milano, Milan, Italy
700    1_
$a Seccia, Teresa Maria $u Hypertension Unit and Specialized Center for Blood Pressure Disorders - Department of Medicine-DIMED, University of Padova, Padova, Italy
700    1_
$a Lin, Yen-Hung $u Division of cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
700    1_
$a Fallo, Francesco $u Department of Medicine -DIMED, University of Padova, Padova, Italy
700    1_
$a Widimsky, Jiri $u 3rd Department of Medicine, Center for Hypertension, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00002723 $t Journal of hypertension $x 1473-5598 $g Roč. 38, č. 10 (2020), s. 1919-1928
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32890264 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101654 $b ABA008
999    __
$a ok $b bmc $g 1690785 $s 1140509
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 38 $c 10 $d 1919-1928 $e - $i 1473-5598 $m Journal of hypertension $n J Hypertens $x MED00002723
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...